Human Immuno-deficiency (HIV) Virus is usually among other disorders associated with cognitive impairment and dementia adding to the burden of the disease in affected individuals and the quality of care. A cross-sectional descriptive study was carried out in a non-governmental organization caring for patients with the disease in Jos, North Central Nigeria. A total of 220 patients attending the Faith Alive Clinic in Jos were randomly selected and studied using instruments such as the Mini-Mental State Examination (MMSE) Modified – HIV Associated Dementia Scale (M-HDS) and the Center for Epidemiologic Study Depression Scale – Revised (CES-D). Most of the patients were female (60.9%), male 31.9% with 48.6% married. Analysis of the different subscales of M-HAD the MMSE reveals significant impairment Psychomotor, memory and recall and the construction functions of the subjects P ≤ 0.000. The prevalence of cognitive impairment/dementia in the study population was 70.9% on M-HDS and 35% on MMSE. The implication of these findings is that clinicians should have reasonable index of suspicion when managing patients that are HIV Sero-positive to be able to identify patients with cognitive problems.
Published in |
Advances in Psychology and Neuroscience (Volume 2, Issue 2-1)
This article belongs to the Special Issue Substance Abuse: Perspectives, Trends, Issues and the Way Forward |
DOI | 10.11648/j.apn.s.2017020201.15 |
Page(s) | 27-30 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Human Immuno-Deficiency Virus, Cognitive Impairment, Dementia Scale, Jos, Mini-Mental State Examination, Depression Scale
[1] | WHO. Global Programme on AIDS current and future dimensions of the HIV/AIDS pandemic: A Capsule Summary, Geneva, Switzerland, 1992. |
[2] | Rispel, C. L, Allanise, C, Metalf, C. A Experiences of stigma and discrimination among HIV- discordant couples in South –Africa, Tanzania and Ukraine. Journal of Social Aspects of HIV/AIDS, vol.12 (1), pp.10-17, 2015. |
[3] | Wong, M. H, Robertson, K. Nakasujja, M. B. Frequency of and risk factors for HAD in an HIV clinic in Sub-Saharan Africa. Neurology, vol. 68 (5), pp.350-355, 2007. |
[4] | Major, M. Satz, P, Janssen, R, Zaudig, M, Starace, F. WHO Neuropsychiatric Aids Study – Cross sectional phase Neuropsychological and Neurological Findings. Archives of General Psychiatry Vol. 51 pp. 51-61, 1994. |
[5] | Sacktor, N The epidemiology of HIV associated Neurological disease in the era of HAART. Journal of Neurology, vol. 8 (12), pp. 115 –121, 2002. |
[6] | Forstein, M. Neuropsychiatric aspects of HIV infection. HIV Medical Alert, vol. 7 (1), pp.1–4, 2003. |
[7] | Cassels, C. Prevalence of HIV related dementia second only to Alzheimer’s and stroke. Neurology, vol. 68, pp.380-385, 2007. |
[8] | Power, C, Selnes, O. A, Grim, J. A, JMcArthur, J. C. HIV dementia scale. A rapid screening test. Journal of Acquired Immune Deficiency Syndrome, vol.8, pp. 273–278, 1995. |
[9] | Howard, E, Grant, I, Ian, P. E, Stuart, A. L Susan. S. Prevalence of Cognitive dysfunction in HIV/AIDS. Neurology of AIDS 2nd ed; London. Oxford University Press, 2005, pp.326–337. |
[10] | Patel, V. N. Mungwira, R. G, Tarumbiswa, T. F, Heikinheimo, T, van Oosterhou, J. J. High Prevalence of suspected HIV-associated dementia in adult Malawian HIV patients. International Journal for STD AIDS, vol. 21 (5), pp. 356-8, 2010. |
[11] | Hinkin, C Comparing the accuracy of two methods in diagnosing HIV–Associated Cognitive Impairment. Journal of Clinical Experiment and Neuropsychology, vol.13 (3), pp. 462–470, 2007. |
[12] | Baiyewu, O, Unverzagt, F. W, Lane, K. A, Gureje, O. The stick design. Journal of International Neuropsychology, vol. 11, pp. 598–605, 2005. |
[13] | Heaton, R. K, Grant, I, Butters, N. The HNRC 500–Neuropsychology of HIV infection at different disease stages. HIV Neuro-behavioral Research Centre. Journal of International Neuropsychology, vol. 1 (3), pp. 231–251, 1995. |
APA Style
Piwuna C. G., Piwuna T. O., Obindo J. T., Tungchama F. P., Bankat M. A. (2017). Cognitive Impairment/Dementia in HIV Patients in a Faith Based Clinic. Advances in Psychology and Neuroscience, 2(2-1), 27-30. https://doi.org/10.11648/j.apn.s.2017020201.15
ACS Style
Piwuna C. G.; Piwuna T. O.; Obindo J. T.; Tungchama F. P.; Bankat M. A. Cognitive Impairment/Dementia in HIV Patients in a Faith Based Clinic. Adv. Psychol. Neurosci. 2017, 2(2-1), 27-30. doi: 10.11648/j.apn.s.2017020201.15
@article{10.11648/j.apn.s.2017020201.15, author = {Piwuna C. G. and Piwuna T. O. and Obindo J. T. and Tungchama F. P. and Bankat M. A.}, title = {Cognitive Impairment/Dementia in HIV Patients in a Faith Based Clinic}, journal = {Advances in Psychology and Neuroscience}, volume = {2}, number = {2-1}, pages = {27-30}, doi = {10.11648/j.apn.s.2017020201.15}, url = {https://doi.org/10.11648/j.apn.s.2017020201.15}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.apn.s.2017020201.15}, abstract = {Human Immuno-deficiency (HIV) Virus is usually among other disorders associated with cognitive impairment and dementia adding to the burden of the disease in affected individuals and the quality of care. A cross-sectional descriptive study was carried out in a non-governmental organization caring for patients with the disease in Jos, North Central Nigeria. A total of 220 patients attending the Faith Alive Clinic in Jos were randomly selected and studied using instruments such as the Mini-Mental State Examination (MMSE) Modified – HIV Associated Dementia Scale (M-HDS) and the Center for Epidemiologic Study Depression Scale – Revised (CES-D). Most of the patients were female (60.9%), male 31.9% with 48.6% married. Analysis of the different subscales of M-HAD the MMSE reveals significant impairment Psychomotor, memory and recall and the construction functions of the subjects P ≤ 0.000. The prevalence of cognitive impairment/dementia in the study population was 70.9% on M-HDS and 35% on MMSE. The implication of these findings is that clinicians should have reasonable index of suspicion when managing patients that are HIV Sero-positive to be able to identify patients with cognitive problems.}, year = {2017} }
TY - JOUR T1 - Cognitive Impairment/Dementia in HIV Patients in a Faith Based Clinic AU - Piwuna C. G. AU - Piwuna T. O. AU - Obindo J. T. AU - Tungchama F. P. AU - Bankat M. A. Y1 - 2017/02/14 PY - 2017 N1 - https://doi.org/10.11648/j.apn.s.2017020201.15 DO - 10.11648/j.apn.s.2017020201.15 T2 - Advances in Psychology and Neuroscience JF - Advances in Psychology and Neuroscience JO - Advances in Psychology and Neuroscience SP - 27 EP - 30 PB - Science Publishing Group UR - https://doi.org/10.11648/j.apn.s.2017020201.15 AB - Human Immuno-deficiency (HIV) Virus is usually among other disorders associated with cognitive impairment and dementia adding to the burden of the disease in affected individuals and the quality of care. A cross-sectional descriptive study was carried out in a non-governmental organization caring for patients with the disease in Jos, North Central Nigeria. A total of 220 patients attending the Faith Alive Clinic in Jos were randomly selected and studied using instruments such as the Mini-Mental State Examination (MMSE) Modified – HIV Associated Dementia Scale (M-HDS) and the Center for Epidemiologic Study Depression Scale – Revised (CES-D). Most of the patients were female (60.9%), male 31.9% with 48.6% married. Analysis of the different subscales of M-HAD the MMSE reveals significant impairment Psychomotor, memory and recall and the construction functions of the subjects P ≤ 0.000. The prevalence of cognitive impairment/dementia in the study population was 70.9% on M-HDS and 35% on MMSE. The implication of these findings is that clinicians should have reasonable index of suspicion when managing patients that are HIV Sero-positive to be able to identify patients with cognitive problems. VL - 2 IS - 2-1 ER -